MedPath

University Of St Andrews

University Of St Andrews logo
🇬🇧United Kingdom
Ownership
-
Established
1413-01-01
Employees
-
Market Cap
-
Website
https://st-andrews.ac.uk

Clinical Trials

8

Active:0
Completed:4

Trial Phases

3 Phases

Phase 1:2
Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (50.0%)
Not Applicable
1 (25.0%)
Phase 2
1 (25.0%)

Mini-AFTERc Intervention for Fear of Cancer Recurrence

Not Applicable
Conditions
Breast Cancer
Fear of Cancer
First Posted Date
2018-12-04
Last Posted Date
2019-05-31
Lead Sponsor
University of St Andrews
Target Recruit Count
133
Registration Number
NCT03763825
Locations
🇬🇧

Queen Margaret Hospital, Dunfermline, NHS Fife, United Kingdom

🇬🇧

Raigmore Hospital, Inverness, NHS Highlands, United Kingdom

🇬🇧

Western General Hospital, Edinburgh, NHS Lothain, United Kingdom

and more 1 locations

A Communication Skills Package to Prevent Fear of Cancer Recurrence

Conditions
Breast Cancer
First Posted Date
2018-03-19
Last Posted Date
2018-10-05
Lead Sponsor
University of St Andrews
Target Recruit Count
74
Registration Number
NCT03468881
Locations
🇬🇧

NHS Lothian Edinburgh Cancer Centre, Edinburgh, United Kingdom

🇬🇧

University of St Andrews, St Andrews, United Kingdom

MapMySmoke: Smoking Cessation App With Geospatial Capture

Phase 1
Conditions
Smoking
Cigarette Smoking
Smoking, Tobacco
First Posted Date
2016-10-13
Last Posted Date
2017-05-22
Lead Sponsor
University of St Andrews
Target Recruit Count
110
Registration Number
NCT02932917

Fear of Cancer Recurrence (FoR) Trajectory During Radiation Treatment

Completed
Conditions
Breast Cancer
First Posted Date
2015-11-06
Last Posted Date
2018-10-01
Lead Sponsor
University of St Andrews
Target Recruit Count
97
Registration Number
NCT02599506
Locations
🇬🇧

NHS Lothian Edinburgh Cancer Centre, Edinburgh, United Kingdom

A Single Session Intervention For Fear Of Recurrence In Breast Cancer Patients

Phase 1
Completed
Conditions
Fear
First Posted Date
2015-02-06
Last Posted Date
2016-01-20
Lead Sponsor
University of St Andrews
Target Recruit Count
16
Registration Number
NCT02357927
Locations
🇬🇧

Breast Cancer Services, Queen Margaret Hospital, Dunfermline, Fife, United Kingdom

  • Prev
  • 1
  • 2
  • Next

News

Pneumagen's Neumifil Shows Promising Results in Phase 2 Influenza Prevention Trial

Pneumagen's intranasal antiviral drug Neumifil demonstrated clinically significant reductions in both incidence and severity of symptomatic influenza infections in a Phase 2 controlled human infection model study.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.